Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Armitage

Showing results (381-390 of 582) with videos related to

Pageof 59
Sort By:
British Journal of Haematology|February 5, 1998
Elevated levels of biologically active soluble CD40 ligand in the serum of patients with chronic lymphocytic leukaemiaA Younes, V Snell, U Consoli, et al.
The Journal of Pediatrics|February 1, 1990
Coronary arteriosclerosis in pediatric heart transplant survivors: limitation of long-term survivalE Pahl, F J Fricker, J Armitage, et al.
BMJ Open|December 1, 2017
Improving hearing and vision in dementia: protocol for a field trial of a new interventionJemma Regan, Piers Dawes, Annie Pye, et al.
Zootaxa|July 6, 2026
<b>The Coleoptera of Panama. I. A first benchmark for the superfamily Dryopoidea</b>Brian J Armitage, William D Shepard, Viterbo Rodriguez, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 15, 1994
Costimulation through CD28 enhances T cell-dependent B cell activation via CD40-CD40L interactionS J Klaus, L M Pinchuk, H D Ochs, et al.
European Journal of Immunology|August 1, 1992
Identification of a source of biologically active CD40 ligandR J Armitage, T A Sato, B M Macduff, et al.
The British Journal of Ophthalmology|November 15, 2015
The impact of donor age and endothelial cell density on graft survival following penetrating keratoplastyM J Wakefield, W J Armitage, M N A Jones, et al.
Clinical Transplants|January 1, 1990
Overview of FK506 in transplantationJ J Fung, K Abu-Elmagd, S Todo, et al.
Eye (London, England)|January 29, 2011
Antiviral treatment following penetrating keratoplasty for herpetic keratitisJ F B Goodfellow, S Nabili, M N A Jones, et al.
Blood|April 1, 1991
Parma international protocol: pilot study of DHAP followed by involved-field radiotherapy and BEAC with autologous bone marrow transplantationT Philip, F Chauvin, J Armitage, et al.
Pageof 59

Showing results (381-390 of 582) with videos related to

Sort By:
Pageof 59
British Journal of Haematology|February 5, 1998
Elevated levels of biologically active soluble CD40 ligand in the serum of patients with chronic lymphocytic leukaemiaA Younes, V Snell, U Consoli, et al.
The Journal of Pediatrics|February 1, 1990
Coronary arteriosclerosis in pediatric heart transplant survivors: limitation of long-term survivalE Pahl, F J Fricker, J Armitage, et al.
BMJ Open|December 1, 2017
Improving hearing and vision in dementia: protocol for a field trial of a new interventionJemma Regan, Piers Dawes, Annie Pye, et al.
Zootaxa|July 6, 2026
<b>The Coleoptera of Panama. I. A first benchmark for the superfamily Dryopoidea</b>Brian J Armitage, William D Shepard, Viterbo Rodriguez, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 15, 1994
Costimulation through CD28 enhances T cell-dependent B cell activation via CD40-CD40L interactionS J Klaus, L M Pinchuk, H D Ochs, et al.
European Journal of Immunology|August 1, 1992
Identification of a source of biologically active CD40 ligandR J Armitage, T A Sato, B M Macduff, et al.
The British Journal of Ophthalmology|November 15, 2015
The impact of donor age and endothelial cell density on graft survival following penetrating keratoplastyM J Wakefield, W J Armitage, M N A Jones, et al.
Clinical Transplants|January 1, 1990
Overview of FK506 in transplantationJ J Fung, K Abu-Elmagd, S Todo, et al.
Eye (London, England)|January 29, 2011
Antiviral treatment following penetrating keratoplasty for herpetic keratitisJ F B Goodfellow, S Nabili, M N A Jones, et al.
Blood|April 1, 1991
Parma international protocol: pilot study of DHAP followed by involved-field radiotherapy and BEAC with autologous bone marrow transplantationT Philip, F Chauvin, J Armitage, et al.
Pageof 59